These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9374327)

  • 1. New research developments increase therapeutic options for thyroid cancer and bone pain palliation.
    Williams JE
    J Nucl Med; 1997 Nov; 38(11):19N-20N, 26N. PubMed ID: 9374327
    [No Abstract]   [Full Text] [Related]  

  • 2. Radionuclides for metastatic bone pain palliation: a need for rational re-evaluation in the new millennium.
    Krishnamurthy GT; Krishnamurthy S
    J Nucl Med; 2000 Apr; 41(4):688-91. PubMed ID: 10768570
    [No Abstract]   [Full Text] [Related]  

  • 3. Samarium-153 lexidronam for painful bone metastases.
    Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radionuclide therapy for painful bone metastases].
    Szefer J; Zuchora Z
    Wiad Lek; 2004; 57(5-6):280-3. PubMed ID: 15518077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain palliation and nuclear medicine.
    McEwan AJ
    Eur J Nucl Med; 1993 Jan; 20(1):1-3. PubMed ID: 7678395
    [No Abstract]   [Full Text] [Related]  

  • 6. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A; Braga FJ; Graeff CF; Baffa O
    Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular radiotherapy.
    Buscombe J; Navalkissoor S
    Clin Med (Lond); 2012 Aug; 12(4):381-6. PubMed ID: 22930888
    [No Abstract]   [Full Text] [Related]  

  • 8. Our experience on pain palliation of bone metastasis with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study.
    Montesano T; Giacomobono S; Acqualagna G; Colandrea M; Di Nicola A; Travascio L; Giancamerla M; D'Apollo R; Toteda M; Ugolini F; Filesi M; Ronga G
    Clin Ter; 2009; 160(3):193-9. PubMed ID: 19756320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted radionuclide therapy for bone metastases.
    Lewington VJ
    Eur J Nucl Med; 1993 Jan; 20(1):66-74. PubMed ID: 7678397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unsealed source therapy of painful bone metastases: an update.
    McEwan AJ
    Semin Nucl Med; 1997 Apr; 27(2):165-82. PubMed ID: 9144858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic radiotherapy: what role will it have in 2001?].
    George B; Douard MC; Rain JD
    Cancer Radiother; 2002 May; 6(3):188-200. PubMed ID: 12116845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.
    Tian JH; Zhang JM; Hou QT; Oyang QH; Wang JM; Luan ZS; Chuan L; He YJ
    Eur J Nucl Med; 1999 Jan; 26(1):2-7. PubMed ID: 9933654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practice guideline for the performance of therapy with unsealed radiopharmaceutical sources.
    Dillehay GL; Ellerbroek NA; Balon H; Brill DR; Grigsby PW; Macklis RM; Mauch PM; Mian TA; Potters L; Silberstein EB; Williams TR; Wong JC; Gaspar LE;
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1299-307. PubMed ID: 16472933
    [No Abstract]   [Full Text] [Related]  

  • 17. Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP.
    Sinzinger H; Weiss K; Hiltunen J
    Anticancer Res; 2009 Aug; 29(8):3393-5. PubMed ID: 19661362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium and samarium therapy for bone metastases from prostate carcinoma.
    Dickie GJ; Macfarlane D
    Australas Radiol; 1999 Nov; 43(4):476-9. PubMed ID: 10901963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide therapy in oncology.
    Clarke SE
    Cancer Treat Rev; 1994 Jan; 20(1):51-71. PubMed ID: 8293428
    [No Abstract]   [Full Text] [Related]  

  • 20. [Radionuclide therapy for the treatment of skeletal metastases of urological malignancies: a forgotten therapy?].
    Badawi JK
    Dtsch Med Wochenschr; 2012 Aug; 137(33):1645-9. PubMed ID: 22875692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.